These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1690609)

  • 1. Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformants.
    Burrows SR; Misko IS; Sculley TB; Schmidt C; Gang D; Moss DJ
    Cell Immunol; 1990 Apr; 127(1):47-55. PubMed ID: 1690609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line.
    Rickinson AB; Moss DJ; Allen DJ; Wallace LE; Rowe M; Epstein MA
    Int J Cancer; 1981 May; 27(5):593-601. PubMed ID: 6169663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component.
    Misko IS; Sculley TB; Schmidt C; Moss DJ; Soszynski T; Burman K
    Cell Immunol; 1991 Feb; 132(2):295-307. PubMed ID: 1846323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures.
    Moss DJ; Rickinson AB; Pope JH
    Int J Cancer; 1979 May; 23(5):618-25. PubMed ID: 222691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. II. Cytotoxic response to repeated stimulation.
    Allen DJ; Rickinson AB; Wallace LE; Rowe M; Moss DJ; Epstein MA
    Cell Immunol; 1982 Feb; 67(1):141-51. PubMed ID: 6176333
    [No Abstract]   [Full Text] [Related]  

  • 8. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
    Chen BP; DeMars R; Hank JA; Sondel PM
    Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
    Moss DJ; Wallace LE; Rickinson AB; Epstein MA
    Eur J Immunol; 1981 Sep; 11(9):686-93. PubMed ID: 6170517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes.
    Moss DJ; Rickinson AB; Pope JH
    Int J Cancer; 1978 Dec; 22(6):662-8. PubMed ID: 214405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation in vitro of EBV-induced specific cytotoxic T cells in autologous serum avoids complications due to self-preferred foetal calf serum-specific T-cell cytotoxicity.
    Misko IS; Kane RG; Pope JH
    Int J Cancer; 1981; 27(4):513-9. PubMed ID: 6268554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants.
    Burrows SR; Misko IS; Sculley TB; Schmidt C; Moss DJ
    J Virol; 1990 Aug; 64(8):3974-6. PubMed ID: 1695259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
    Wilson AD; Morgan AJ
    J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus.
    Misko IS; Moss DJ; Pope JH
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4247-50. PubMed ID: 6254017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of enhancement of Epstein-Barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, TPA, with special reference to lowering of cytotoxicity of T cells.
    Harada S; Katsuki T; Yamamoto H; Hinuma Y
    Int J Cancer; 1981 May; 27(5):617-23. PubMed ID: 6270019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term C-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures.
    Rickinson AB; Moss DJ; Pope JH
    Int J Cancer; 1979 May; 23(5):610-7. PubMed ID: 222690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
    Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
    Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method.
    Tanaka Y; Sugamura K; Hinuma Y; Sato H; Okochi K
    J Immunol; 1980 Oct; 125(4):1426-31. PubMed ID: 6157733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.